Saroja Pharma Industries India Limited (NSE:SAROJA)
India · Delayed Price · Currency is INR 33.45
+0.10 (0.30%)
Mar 4, 2026, 3:21 PM IST
NSE:SAROJA Revenue
Saroja Pharma Industries India had revenue of 383.60M INR in the half year ending September 30, 2025, with 81.64% growth. This brings the company's revenue in the last twelve months to 733.63M, up 91.67% year-over-year. In the fiscal year ending March 31, 2025, Saroja Pharma Industries India had annual revenue of 537.27M with 32.11% growth.
Revenue (ttm)
733.63M
Revenue Growth
+91.67%
P/S Ratio
0.18
Revenue / Employee
61.14M
Employees
12
Market Cap
134.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 537.27M | 130.58M | 32.11% |
| Mar 31, 2024 | 406.69M | -95.24M | -18.97% |
| Mar 31, 2023 | 501.93M | -54.39M | -9.78% |
| Mar 31, 2022 | 556.33M | 189.71M | 51.75% |
| Mar 31, 2021 | 366.62M | 195.82M | 114.65% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Purv Flexipack | 5.59B |
| Visaman Global Sales | 2.37B |
| De Neers Tools | 1.48B |
| Aspire & Innovative Advertising | 1.27B |
| Khaitan (India) | 1.02B |
| AKG Exim | 989.21M |
| Silkflex Polymers (India) | 843.23M |
| Prizor Viztech | 821.07M |